NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

325 hedge funds and large institutions have $7.8B invested in Neurocrine Biosciences in 2019 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 142 increasing their positions, 98 reducing their positions, and 49 closing their positions.

Holders
325
Holders Change
-5
Holders Change %
-1.52%
% of All Funds
7.05%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.15%
New
45
Increased
142
Reduced
98
Closed
49
Calls
$108M
Puts
$77.1M
Net Calls
+$30.9M
Net Calls Change
+$2.03M

Top Buyers

1
O
1
OrbiMed
New York
$162M
2
Capital International Investors
2
Capital International Investors
California
$390M
3
HM
3
HealthCor Management
New York
$134M
4
DCP
4
DSM Capital Partners
Florida
$61.3M
5
Millennium Management
5
Millennium Management
New York
$49.3M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$920M
2
Artisan Partners
2
Artisan Partners
Wisconsin
$24.9M
3
CAM
3
Close Asset Management
United Kingdom
$24K
4
PA
4
Perceptive Advisors
New York
$331M
5
TCM
5
TimesSquare Capital Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$920M 10,437,053 -2,579,538 -20%
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$776M 8,811,961 +4,547 +0.1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$719M 8,155,857 +76,039 +0.9%
BlackRock
4
BlackRock
New York
$484M 5,495,336 +516,419 +10%
Capital International Investors
5
Capital International Investors
California
$390M 4,426,600 +901,600 +26%
PA
6
Perceptive Advisors
New York
$331M 3,758,662 -849,892 -18%
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$306M 3,476,150 -533,213 -13%
BB
8
BB Biotech
Switzerland
$297M 3,366,786 +23,696 +0.7%
Franklin Resources
9
Franklin Resources
California
$180M 2,039,138 +14,200 +0.7%
State Street
10
State Street
Massachusetts
$178M 2,018,154 +177,309 +10%
Invesco
11
Invesco
Georgia
$169M 1,922,918 -205,944 -10%
O
12
OrbiMed
New York
$162M 1,833,200 +1,339,000 +271%
HM
13
HealthCor Management
New York
$134M 1,516,090 +747,460 +97%
AllianceBernstein
14
AllianceBernstein
Tennessee
$97.3M 1,104,459 +34,243 +3%
BBA
15
Baker Bros. Advisors
New York
$96.8M 1,098,670 +368,315 +50%
First Trust Advisors
16
First Trust Advisors
Illinois
$95.4M 1,083,057 -216,398 -17%
Deutsche Bank
17
Deutsche Bank
Germany
$90.3M 1,024,635 +189,878 +23%
PAMU
18
Pictet Asset Management (UK)
United Kingdom
$86.3M 979,208 +39,729 +4%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$84.1M 954,670 -14,763 -2%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$83.6M 949,129 +41,837 +5%
Norges Bank
21
Norges Bank
Norway
$75.5M 856,611 – –
RSCM
22
Rock Springs Capital Management
Maryland
$74.4M 844,500 +55,900 +7%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$66.7M 756,873 +134,400 +22%
Two Sigma Investments
24
Two Sigma Investments
New York
$64.3M 729,800 -22,420 -3%
DCP
25
DSM Capital Partners
Florida
$61.3M 696,182 +696,182 New
1
2 3 4 5